Text Size

Asthma in the Elderly: The Role of Exhaled Nitric Oxide Measurements

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Michele Columbo, M.D., Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
ClinicalTrials.gov Identifier:
NCT00939354
First received: July 14, 2009
Last updated: November 16, 2012
Last verified: November 2012
History of Changes
  Purpose

This study will investigate the importance of exhaled nitric oxide measurements in subjects with asthma age 65 and older. This group of patients has been ignored in most previous asthma studies.


Condition
Asthma

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Asthma in the Elderly: The Role of Exhaled Nitric Oxide Measurements

Resource links provided by NLM:

MedlinePlus related topics: Asthma
U.S. FDA Resources

Further study details as provided by Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.:

Primary Outcome Measures:
  • Exhaled Nitric Oxide (FENO) levels and their changes with time [ Time Frame: One year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Correlations of FENO with subjects' demographics, comorbidities, treatment, symptoms, or spiromentric values [ Time Frame: One year ] [ Designated as safety issue: No ]

Enrollment: 30
Study Start Date: July 2009
Study Completion Date: February 2011
Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   65 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Subjects with asthma over the age of 65 who are currently followed in our practice

Criteria

Inclusion Criteria:

  • Subjects with asthma over the age of 65 followed in our practice, non-smokers and able to give informed consent to participate in the study

Exclusion Criteria:

  • Smokers, subjects of diminished mental capacity
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00939354

Sponsors and Collaborators
Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
Investigators
Principal Investigator: Albert S Rohr, M.D. Rohr and Columbo Associates
  More Information

No publications provided

Responsible Party: Michele Columbo, M.D., Co-Investigator, Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
ClinicalTrials.gov Identifier: NCT00939354     History of Changes
Other Study ID Numbers: F/N-R09-2839B
Study First Received: July 14, 2009
Last Updated: November 16, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.:
Asthma in subjects over the age of 65

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases
Nitric Oxide
Bronchodilator Agents
Autonomic Agents
Peripheral Nervous System Agents
 Physiological Effects of Drugs
Pharmacologic Actions
Anti-Asthmatic Agents
Respiratory System Agents
Therapeutic Uses
Free Radical Scavengers
Antioxidants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Endothelium-Dependent Relaxing Factors
Vasodilator Agents
Cardiovascular Agents
Protective Agents

ClinicalTrials.gov processed this record on May 22, 2013